BPA Call HHSI246201800069B-75H71118F27002
Award Date 5/4/18
Potential Completion Date 3/19/19
Potential Value $110K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wayne, PA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Emergent Devices Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at one hundred thirty-nine thousand four hundred fifty-nine dollars and thirty-two cents ($139,459.32) by the Department of Health and Human Services Indian Health Service to store a stock of Narcan for warehouse customers under the Pharmaceuticals and Drugs Federal Supply Schedule master contract. Performance will take place in Wayne, Pennsylvania with all work completed by December 31,...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical products. The $631,488.00 award is a delivery order under Emergent Devices' existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the provision of pharmaceuticals, with no set-aside designation. Emergent Devices has previously received federal contracts and...
- This is a delivery order awarded by the Department of Health and Human Services Indian Health Service to Emergent Devices, Inc., a for-profit manufacturer, for the provision of NARCAN nasal spray. The delivery order has a firm-fixed price of $151,015.20 and was issued under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB contract. The order is for the delivery of NARCAN nasal spray to NSSC customers, which likely refers to the National Supply Service Center that provides...
- The Department of Health and Human Services Indian Health Service awarded a $780,528 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Emergent Devices Inc. for the purchase of Naloxone Hydrochloride Nasal Spray, also known as Narcan, for storage and distribution to Native American health care facilities from the National Supply Service Center warehouse in Oklahoma City, Oklahoma. The firm fixed price order runs from November 30, 2021 through December 31, 2021 and...
- The Department of Health and Human Services Indian Health Service awarded a $564,186 delivery order to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order is for Narcan nasal spray to be provided to the National Supply Service Center's customers. Narcan is an opioid antagonist used to rapidly reverse opioid overdoses. Performance will take place in Oklahoma City, Oklahoma over a period of one month from May 7 to June 7, 2021....
- The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...
- The Department of Veterans Affairs Veterans Health Administration awarded a $678,720 delivery order to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs GSA Schedule. The contract calls for Emergent Devices to provide naloxone nasal spray to VHA networks in support of opioid overdose prevention efforts. Performance will take place in Wayne, Pennsylvania over a 10-day period concluding in early May. As a firm fixed price order placed under an existing GSA vehicle, the contract...
- This is a $1,696.00 firm-fixed price delivery order awarded to Emergent Devices, Inc. by the Federal Correctional Institution Ashland, a civilian agency, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. The order is for NARCAN, an opioid overdose reversal medication. This delivery order supports the agency's healthcare, law enforcement, and public safety missions by providing access to critical overdose prevention and harm reduction resources. Emergent Devices,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA - VHA) awarded a $665,184 delivery order contract to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs (FSS-61-IB) master agreement on the General Services Administration (GSA) Federal Supply Schedule. Emergent Devices Inc. will provide 69547-0353-02 Naloxone to the VA - VHA for use between November 29, 2021 and January 31, 2022. The contract has a firm fixed price and...
- This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70052-HHSI246201800069BBlanket Purchase Agreement
- HHSI246201800069B-75H71118F27002BPA Call
The Department of Health and Human Services Indian Health Service awarded a Firm Fixed Price contract to Emergent Devices, Inc. for $110,000.00 to provide pharmaceutical store stock items for the NSSC Warehouse customers. This contract is a BPA Call under Emergent Devices' Federal Supply Schedule 65 IB contract to supply drugs and hematology products to the Veterans Health Administration. The contract has no set-aside designation and was completed on March 19, 2019. Emergent Devices, a for-profit manufacturer, has previously held other contract vehicles with government agencies to provide naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse.
Generated 3/22/24, 1:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $110.0k | 5/4/18 |